Cost-Effectiveness of Take-Home Naloxone for the Prevention of Overdose Fatalities among Heroin Users in the United Kingdom: Supplemental Materials

Langham, S, Wright, A, Kenworthy, J, Grieve, R and Dunlop, WC. 2018. Cost-Effectiveness of Take-Home Naloxone for the Prevention of Overdose Fatalities among Heroin Users in the United Kingdom: Supplemental Materials. [Online]. Value in Health. Available from: https://doi.org/10.1016/j.jval.2017.07.014

Langham, S, Wright, A, Kenworthy, J, Grieve, R and Dunlop, WC. Cost-Effectiveness of Take-Home Naloxone for the Prevention of Overdose Fatalities among Heroin Users in the United Kingdom: Supplemental Materials [Internet]. Value in Health; 2018. Available from: https://doi.org/10.1016/j.jval.2017.07.014

Langham, S, Wright, A, Kenworthy, J, Grieve, R and Dunlop, WC (2018). Cost-Effectiveness of Take-Home Naloxone for the Prevention of Overdose Fatalities among Heroin Users in the United Kingdom: Supplemental Materials. [Data Collection]. Value in Health. https://doi.org/10.1016/j.jval.2017.07.014

Description

Data capture method Simulation
Date (Date published in a 3rd party system) 4 February 2018
Language(s) of written materials English
Data Creators Langham, S, Wright, A, Kenworthy, J, Grieve, R and Dunlop, WC
LSHTM Faculty/Department Faculty of Public Health and Policy > Dept of Health Services Research and Policy
Participating Institutions Maverex Ltd., Manchester, United Kingdom, Mundipharma International Ltd., Cambridge, United Kingdom, London School of Hygiene & Tropical Medicine, London, United Kingdom
Date Deposited 02 May 2018 16:39
Last Modified 08 Jul 2021 12:52
Publisher Value in Health

Share

Downloads

Data not available from this repository.

Downloads

View details

Metrics & Citations

Google Scholar